{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T12:27:50Z","timestamp":1775737670309,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T00:00:00Z","timestamp":1551225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40644-019-0189-5","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T06:06:06Z","timestamp":1551247566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: a comparative study of pharmacokinetic models and correlation with mRECIST criteria"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1985-5052","authenticated-orcid":false,"given":"Martina","family":"Vivoda Tom\u0161i\u010d","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sotirios","family":"Bisdas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viljem","family":"Kova\u010d","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Ser\u0161a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarina","family":"\u0160urlan Popovi\u010d","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,27]]},"reference":[{"issue":"2","key":"189_CR1","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.athoracsur.2017.09.036","volume":"105","author":"SA Saddoughi","year":"2018","unstructured":"Saddoughi SA, Abdelsattar ZM, Blackmon SH. National Trends in the epidemiology of malignant pleural mesothelioma: a National Cancer Data Base Study. Ann Thorac Surg. 2018;105(2):432\u20137.","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"189_CR2","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.lungcan.2015.08.012","volume":"90","author":"L Cheng","year":"2015","unstructured":"Cheng L, Tunariu N, Collins DJ, Blackledge MD, Riddell AM, Leach MO, et al. Response evaluation in mesothelioma: beyond RECIST. Lung Cancer. 2015;90(3):433\u201341.","journal-title":"Lung Cancer"},{"issue":"6","key":"189_CR3","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/nbm.1093","volume":"19","author":"SM Galbraith","year":"2006","unstructured":"Galbraith SM. MR in oncology drug development. NMR Biomed. 2006;19(6):681\u20139.","journal-title":"NMR Biomed"},{"issue":"6","key":"189_CR4","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1378\/chest.129.6.1570","volume":"129","author":"FL Giesel","year":"2006","unstructured":"Giesel FL, Bischoff H, von Tengg-Kobligk H, Weber MA, Zechmann CM, Kauczor HU, et al. Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: a feasibility study of noninvasive assessment, therapeutic follow-up, and possible predictor of improved outcome. Chest. 2006;129(6):1570\u20136.","journal-title":"Chest"},{"key":"189_CR5","doi-asserted-by":"crossref","unstructured":"Sourbron SP, Buckley DL. Classic models for dynamic contrast-enhanced MRI. NMR Biomed. 2013;26(8):1004-27.","DOI":"10.1002\/nbm.2940"},{"issue":"6","key":"189_CR6","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/jmri.22795","volume":"34","author":"TS Koh","year":"2011","unstructured":"Koh TS, Bisdas S, Koh DM, Thng CH. Fundamentals of tracer kinetics for dynamic contrast-enhanced MRI. J Magn Reson Imaging. 2011;34(6):1262\u201376.","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"189_CR7","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/mrm.22217","volume":"63","author":"SB Donaldson","year":"2010","unstructured":"Donaldson SB, West CM, Davidson SE, Carrington BM, Hutchison G, Jones AP, et al. A comparison of tracer kinetic models for T1-weighted dynamic contrast-enhanced MRI: application in carcinoma of the cervix. Magn Reson Med. 2010;63(3):691\u2013700.","journal-title":"Magn Reson Med"},{"issue":"9","key":"189_CR8","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1002\/nbm.1680","volume":"24","author":"TS Koh","year":"2011","unstructured":"Koh TS, Thng CH, Hartono S, Tai BC, Rumpel H, Ong AB, et al. A comparative study of dynamic contrast-enhanced MRI parameters as biomarkers for anti-angiogenic drug therapy. NMR Biomed. 2011;24(9):1169\u201380.","journal-title":"NMR Biomed"},{"issue":"6","key":"189_CR9","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1002\/mrm.21814","volume":"61","author":"JH Naish","year":"2009","unstructured":"Naish JH, Kershaw LE, Buckley DL, Jackson A, Waterton JC, Parker GJ. Modeling of contrast agent kinetics in the lung using T1-weighted dynamic contrast-enhanced MRI. Magn Reson Med. 2009;61(6):1507\u201314.","journal-title":"Magn Reson Med"},{"issue":"2","key":"189_CR10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/CAD.0b013e32834d7a1c","volume":"23","author":"V Kovac","year":"2012","unstructured":"Kovac V, Zwitter M, Rajer M, Marin A, Debeljak A, Smrdel U, et al. A phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesothelioma. Anti-Cancer Drugs. 2012;23(2):230\u20138.","journal-title":"Anti-Cancer Drugs"},{"issue":"6","key":"189_CR11","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/CAD.0b013e32833ab7a0","volume":"21","author":"M Zwitter","year":"2010","unstructured":"Zwitter M, Kovac V, Rajer M, Vrankar M, Smrdel U. Two schedules of chemotherapy for patients with non-small cell lung cancer in poor performance status: a phase II randomized trial. Anti-Cancer Drugs. 2010;21(6):662\u20138.","journal-title":"Anti-Cancer Drugs"},{"issue":"14","key":"189_CR12","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol. 2003;21(14):2636\u201344.","journal-title":"J Clin Oncol"},{"issue":"6","key":"189_CR13","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/01.rli.0000209607.99200.53","volume":"41","author":"M Heilmann","year":"2006","unstructured":"Heilmann M, Kiessling F, Enderlin M, Schad LR. Determination of pharmacokinetic parameters in DCE MRI: consequence of nonlinearity between contrast agent concentration and signal intensity. Investig Radiol. 2006;41(6):536\u201343.","journal-title":"Investig Radiol"},{"issue":"2","key":"189_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/annonc\/mdh059","volume":"15","author":"MJ Byrne","year":"2004","unstructured":"Byrne MJ, Nowak AK. Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol. 2004;15(2):257\u201360.","journal-title":"Ann Oncol"},{"issue":"1","key":"189_CR15","first-page":"101","volume":"27","author":"D Gandhi","year":"2006","unstructured":"Gandhi D, Chepeha DB, Miller T, Carlos RC, Bradford CR, Karamchandani R, et al. Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy. AJNR Am J Neuroradiol. 2006;27(1):101\u20136.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"189_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.tranon.2015.11.016","volume":"9","author":"A Tudorica","year":"2016","unstructured":"Tudorica A, Oh KY, Chui SY, Roy N, Troxell ML, Naik A, et al. Early prediction and evaluation of breast Cancer response to neoadjuvant chemotherapy using quantitative DCE-MRI. Transl Oncol. 2016;9(1):8\u201317.","journal-title":"Transl Oncol"},{"issue":"2","key":"189_CR17","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1148\/radiol.2392021099","volume":"239","author":"AR Padhani","year":"2006","unstructured":"Padhani AR, Hayes C, Assersohn L, Powles T, Makris A, Suckling J, et al. Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical results. Radiology. 2006;239(2):361\u201374.","journal-title":"Radiology"},{"issue":"6","key":"189_CR18","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1002\/mrm.22573","volume":"64","author":"LE Kershaw","year":"2010","unstructured":"Kershaw LE, Cheng HL. Temporal resolution and SNR requirements for accurate DCE-MRI data analysis using the AATH model. Magn Reson Med. 2010;64(6):1772\u201380.","journal-title":"Magn Reson Med"},{"issue":"8","key":"189_CR19","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1007\/s00330-006-0566-x","volume":"17","author":"F Kiessling","year":"2007","unstructured":"Kiessling F, Jugold M, Woenne EC, Brix G. Non-invasive assessment of vessel morphology and function in tumors by magnetic resonance imaging. Eur Radiol. 2007;17(8):2136\u201348.","journal-title":"Eur Radiol"},{"issue":"3","key":"189_CR20","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/jmri.21060","volume":"26","author":"HJ Yu","year":"2007","unstructured":"Yu HJ, Chen JH, Mehta RS, Nalcioglu O, Su MY. MRI measurements of tumor size and pharmacokinetic parameters as early predictors of response in breast cancer patients undergoing neoadjuvant anthracycline chemotherapy. J Magn Reson Imaging. 2007;26(3):615\u201323.","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"189_CR21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s00330-002-1654-1","volume":"13","author":"K Wasser","year":"2003","unstructured":"Wasser K, Klein SK, Fink C, Junkermann H, Sinn HP, Zuna I, et al. Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution. Eur Radiol. 2003;13(1):80\u20137.","journal-title":"Eur Radiol"},{"issue":"2","key":"189_CR22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1158\/0008-5472.CAN-11-2464","volume":"72","author":"AG Sorensen","year":"2012","unstructured":"Sorensen AG, Emblem KE, Polaskova P, Jennings D, Kim H, Ancukiewicz M, et al. Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusion. Cancer Res. 2012;72(2):402\u20137.","journal-title":"Cancer Res"},{"issue":"1","key":"189_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00062-014-0328-0","volume":"26","author":"S Bisdas","year":"2016","unstructured":"Bisdas S, Smrdel U, Bajrovic FF, Surlan-Popovic K. Assessment of progression-free-survival in glioblastomas by Intratreatment dynamic contrast-enhanced MRI. Clin Neuroradiol. 2016;26(1):39\u201345.","journal-title":"Clin Neuroradiol"},{"issue":"Suppl 1","key":"189_CR24","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1007\/s00259-010-1448-7","volume":"37","author":"G Brix","year":"2010","unstructured":"Brix G, Griebel J, Kiessling F, Wenz F. Tracer kinetic modelling of tumour angiogenesis based on dynamic contrast-enhanced CT and MRI measurements. Eur J Nucl Med Mol Imaging. 2010;37(Suppl 1):S30\u201351.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"189_CR25","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.acra.2007.12.014","volume":"15","author":"FL Giesel","year":"2008","unstructured":"Giesel FL, Choyke PL, Mehndiratta A, Zechmann CM, von Tengg-Kobligk H, Kayser K, et al. Pharmacokinetic analysis of malignant pleural mesothelioma-initial results of tumor microcirculation and its correlation to microvessel density (CD-34). Acad Radiol. 2008;15(5):563\u201370.","journal-title":"Acad Radiol"},{"issue":"2","key":"189_CR26","first-page":"147","volume":"4","author":"Y Gordon","year":"2014","unstructured":"Gordon Y, Partovi S, Muller-Eschner M, Amarteifio E, Bauerle T, Weber MA, et al. Dynamic contrast-enhanced magnetic resonance imaging: fundamentals and application to the evaluation of the peripheral perfusion. Cardiovasc Diagn Ther. 2014;4(2):147\u201364.","journal-title":"Cardiovasc Diagn Ther"},{"issue":"6","key":"189_CR27","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1002\/jmri.24061","volume":"38","author":"JR Ledsam","year":"2013","unstructured":"Ledsam JR, Hodgson R, Moots RJ, Sourbron SP. Modeling DCE-MRI at low temporal resolution: a case study on rheumatoid arthritis. J Magn Reson Imaging. 2013;38(6):1554\u201363.","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"189_CR28","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.lungcan.2015.07.011","volume":"90","author":"SG Armato 3rd","year":"2015","unstructured":"Armato SG 3rd, Coolen J, Nowak AK, Robinson C, Gill RR, Straus C, et al. Imaging in pleural mesothelioma: a review of the 12th international conference of the international mesothelioma interest group. Lung Cancer. 2015;90(2):148\u201354.","journal-title":"Lung Cancer"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-019-0189-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40644-019-0189-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-019-0189-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T19:14:20Z","timestamp":1582744460000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerimagingjournal.biomedcentral.com\/articles\/10.1186\/s40644-019-0189-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,27]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["189"],"URL":"https:\/\/doi.org\/10.1186\/s40644-019-0189-5","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,27]]},"assertion":[{"value":"3 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the national ethics committee no. 21p\/09\/13 and all patients gave informed consent for participating in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"10"}}